Acs Sensors

OCT 9, 2026 · JOURNAL ARTICLE

PD-L1-Targeted and ROS-Responsive Nanoplatform for Simultaneous Chemotherapy and Dual-Modal Imaging of Treatment Response in Triple-Negative Breast Cancer

Acs Sensors

Abstract The evaluation of treatment response in triple-negative breast cancer (TNBC) still primarily relies on tumor size and ex vivo analyses, which provide very limited informat

OCT 5, 2026 · JOURNAL ARTICLE

Molecular Programming of CRISPR Diagnostics: From Target Recognition to Field Deployment

Acs Sensors

Abstract Rapid and accurate diagnostics are essential for controlling emerging infectious diseases and antimicrobial resistance, yet CRISPR assays with exceptional analytical sensi

SEP 18, 2026 · JOURNAL ARTICLE

Optimizing the Hinge Length of Chimeric Antigen Receptor with a DdFP-Based Immunological Synapse Biosensor

Acs Sensors

Abstract Chimeric antigen receptor (CAR)-T cell therapy has emerged as a transformative cancer immunotherapy, employing genetic engineering to express CARs in patient T cells. CARs

SEP 8, 2026 · JOURNAL ARTICLE

CRISPR-Based Diagnostic Assay for Point-of-Care Detection of Methicillin-Resistant Staphylococcus aureus in patients with Bloodstream Infections

Acs Sensors

A prospective multicenter clinical evaluation demonstrating 100% sensitivity for S. aureus detection in 350 patients with suspected bacteremia, but limited by small MRSA case numbers (n=8) and lack of specificity data, requiring confirmation in larger MRSA-enriched cohorts before clinical implementation.

AUG 11, 2026 · JOURNAL ARTICLE

Noninvasive Viability Profiling of 3D Spheroids via Flow-through Electrical Impedance Spectroscopy

Acs Sensors

First-in-application proof-of-concept study demonstrating label-free viability profiling of individual spheroids using EIS; validation against conventional assays is present but the work is methodological, single-center, and lacks clinical outcome or disease-relevant efficacy data.